Veeva Systems Inc (VEEV) stock analysis
Veeva Systems Inc (VEEV) clears 3 of this site's 8 mechanical value filters, 6 of 8 Buffett-style checks and 3 of 5 Lynch-style checks. At $322.55 it trades 86.7% above this site's neutral DCF value (a margin of safety of -86.7%). Its earnings quality rates Mixed and it returns −0.6% to shareholders net of dilution. Figures are as of October 23, 2026, from SEC filings and market data refreshed weekly; this is educational analysis, not investment advice.
Data as of October 23, 2026. Refreshed weekly from SEC filings and market data.
What does Veeva Systems do?
Veeva Systems sells cloud software to drug and life science companies for managing sales, clinical trials and regulatory work.
Brands and businesses it owns
- Veeva Vault
- Veeva CRM
What stands out about Veeva Systems?
- The share price implies 24.0% yearly growth. At $322.55, VEEV's free cash flow of $10.12 per share would have to grow 24.0% a year, fading to 2.5% by year 10, for this site's DCF (10% discount rate) to match the price. This site's baseline starts at 8%, so the price asks for more growth than the baseline. Change the assumptions.
- Misses 3 of the 8 value filters. It fails Trailing P/E < 25 (51.49), PEG Ratio < 1.5 (2.09) and Price/Sales < 7 (15.11); the other 3 pass and 2 were not evaluated. See every filter.
- Strongest against peers: net margin. At 29.3% (peer median 9.3%) it ranks 1st of 34 among health care stocks this site tracks. See the ranking.
- Weakest against peers: P/E ratio. At 51.5× (peer median 24.6×) it ranks 31st of 32 among health care stocks this site tracks. See the ranking.
- Earnings quality: Mixed · 1 flag, 1 watch. Beneish M-score −2.62 · accruals −6.2% of assets · 159% of profit arrived as cash · stock comp 14.8% of revenue · share count +1.1% a year. From the latest 10-K (year to Jan 2026). See the Earnings Quality Screener.
How has Veeva Systems' share price moved?
The interactive price chart needs JavaScript.
Is Veeva Systems undervalued? The value diligence check
Every value-investing signal this site computes for this stock, gathered in one place: the same real numbers from the tools below, not a new score.
- Margin of safety (DCF) -86.7%
- P/E vs. its own history 51.5x · near the cheap end Real range: 37.5x–89.9x over 5 years (net income per diluted share from each fiscal year's 10-K, paired with the real closing price at that fiscal year-end).
- Wall St. analyst rating Buy · 4.00/5 36 analysts this month: 10 strong buy, 17 buy, 8 hold, 1 sell, 0 strong sell (Finnhub). Up from 3.94 last month.
- Altman Z″-Score (bankruptcy risk) 11.21 · Safe zone
- Earnings quality (is the profit real?) Mixed · 1 flag, 1 watch Beneish M-score −2.62 · accruals −6.2% of assets · 159% of profit arrived as cash · stock comp 14.8% of revenue · share count +1.1% a year. From the latest 10-K (year to Jan 2026) - see the Earnings Quality Screener for how each check is scored.
- Shareholder yield (cash back to owners) −0.6% net Latest fiscal year (2026): dividends 0.0% + buybacks 0.3% − stock comp 0.9%, as a share of today's market cap. Stock comp outruns what comes back in cash. Over 11 years its split-adjusted share count rose 16%. See Shareholder Yield Leaders.
- Capital needed to grow (See's test) $0.43 per $1 of new profit · See's-like Operating profit $167M → $679M, capital needed $124M → $343M, 2017–2026 (3-year averages); return on capital now 198% before tax. Buffett's See's Candies needed $0.42 per $1 of new profit, FlightSafety $3.20, a typical grower about $5. See Capital-Light Compounders.
- PEG (growth at a reasonable price) 2.09 · Well above fair P/E 51.5× ÷ 24.7% a year of growth behind it. 234th lowest of 447 stocks with a usable PEG. Lynch's fair value is a PEG of 1; a very high PEG usually means almost no growth, a very low one a profit spike. See PEG Ratio Ranking.
- Compounder lenses (4) 1 of 4 · misses real profit, cash back, price Capital-light growth: cleared; Profit is real: not cleared (1 earnings-quality flag); Cash to owners: not cleared (−0.7% a year net); Fair price (PEG): not cleared (PEG 2.09, over 1.5). See Compounders at a Fair Price, which also lets you move the PEG bar.
- Value trap check Clear
- Munger's Inversion Check 3 flags
- Standing vs. sector peers 3 of 6 measures above the median Compared with the 33 other health care stocks this site tracks: 3 in the top third, 2 in the bottom third.
How does Veeva Systems compare with its peers?
3 of 6 measures sit above the median of the 33 other health care stocks tracked here, 3 in the top third and 2 in the bottom third.
- P/E ratiolower is cheaper · peer median 24.6× 51.5× ✕31st of 32
- Free-cash-flow yieldhigher is cheaper · peer median 5.5% 3.1% ✕29th of 34
- Return on equityhigher is better · peer median 15% 14% –19th of 34
- Net marginhigher is better · peer median 9.3% 29.3% ✓1st of 34
- Revenue growthhigher is better, year on year · peer median 8.6% 16.5% ✓5th of 34
- Debt / equitylower is safer · peer median 0.69 0.00 ✓1st of 34
Peers are the stocks this site tracks in the same sector group, not every listed competitor. The bar runs from the weakest peer (left) to the strongest (right); the tick is the middle. Measures that don't apply to a sector (cash-flow yield for banks, debt for financials) are left out.
What would Buffett & Lynch say?
Buffett's checklist is built around durable, profitable businesses bought at sensible prices, and VEEV doesn't clear enough of it yet. In its favor: VEEV is currently earning a strong return on shareholders' equity, and has kept that profitability up over five years, not just this year, carries a conservative amount of debt relative to equity, converts sales into profit at healthy margins, has grown earnings per share at a solid clip over five years, and earns many times its interest expense, so debt service isn't a worry. Where it comes up short: VEEV is trading above what a conservative discounted-cash-flow estimate says it's worth right now, and trades rich relative to owner earnings, the real cash the business could pay out.
- ROE (TTM) > 11% ✓
- ROE (5yr avg) > 11% ✓
- Debt/Equity < 0.5 ✓
- Pretax margin > 15% ✓
- EPS growth (5yr) > 7% ✓
- Interest coverage > 5x ✓
- Trading below intrinsic value (DCF) ✕
- Price vs. owner earnings < 25x ✕
- Bonus: returning capital via buybacks FY2026
Lynch looked for growth stories that weren't overpriced for that growth, and VEEV falls short of his bar. In its favor: VEEV is growing earnings 20-50% a year, his classic fast-grower zone, isn't leaning on debt to fund that growth, and is generating real cash to back up a fast grower's higher price tag. Where it comes up short: VEEV doesn't clear the tighter PEG bar a fast grower needs to justify its pace, and is priced above what he'd pay even for a company growing this quickly.
- PEG < 1 (stricter for fast growers) ✕
- EPS growth 20%-50% ✓
- Debt/Equity < 0.5 ✓
- P/E < 40 ✕
- Price/FCF < 40 ✓
Quantitative approximations of each investor's documented approach, not endorsed by either investor or their estates - commentary, not this site's actual ranking criteria. Buffett never published a numeric checklist: only 2 of his 8 checks here trace to his own documented concepts ("owner earnings," from his 1986 shareholder letter, and "price is what you pay, value is what you get," his case against fixed P/E/P/B ceilings) - the other 6 (ROE, debt, margins, growth, interest coverage) use commonly-cited thresholds that are not numbers he himself published. The 8 hard filters below (plus the Munger check and Graham margin of safety) are this site's real, mechanical screen and are computed completely independently of the checklists above.
Berkshire Hathaway's own filing
Which of the 8 value filters does Veeva Systems pass?
- Market Cap > $25B $52.3B
- Trailing P/E < 25 51.49
- PEG Ratio < 1.5 2.09
- Price/Book < 8 7.03
- Price/Sales < 7 15.11
- EPS Growth YoY > -5% +38.7%
- vs 50-day MA (±12%) Not evaluated †
- vs 200-day MA (±12%) Not evaluated †
What is Veeva Systems' margin of safety?
History tracking starts this week - check back in a future week to see how this has moved.
Where is Veeva Systems in its 52-week range?
What is the short interest in Veeva Systems?
4,896,341 shares short as of 2026-09-30 (FINRA settlement date). Reported twice a month, so this only changes roughly every two weeks, not daily.
What could go wrong with Veeva Systems? Munger's inversion check
"Invert, always invert." Instead of reasons to buy, these are reasons to hesitate, not a verdict, and not everything worth knowing about a business.
- Margin of safety, even in the bull case -10%
- Short interest under 5% of float 3.3%
- Passes most of the 6 fundamental filters 3/6 passed
- Price run-up backed by value, not just momentum +113% off 52wk low
Doesn't cover circle of competence, management quality, or accounting concerns: those need judgment, not data.
How much have Veeva Systems shareholders gained per year?
Earnings growth per share plus dividend.
An earnings-based proxy, not a stock-price total return - it doesn't capture multiple expansion/contraction or reinvested dividends. EPS from VEEV's own 10-K filings; dividend yield is the current trailing yield on today's price, from the same weekly fetch as the rest of this site.
What do Veeva Systems' 10-year financials show?
From VEEV's own 10-K filings (SEC EDGAR): up to the last 10 fiscal years. Press any year's bars for the exact figures.
Frequently asked questions about Veeva Systems
What kind of company is Veeva Systems?
Veeva Systems sells cloud software to drug and life science companies for managing sales, clinical trials and regulatory work. Brands and businesses it owns include Veeva Vault and Veeva CRM. This site groups it with Health Care stocks.
Is Veeva Systems trading above or below its DCF value?
At $322.55, VEEV trades 86.7% above this site's neutral DCF value of $172.74 per share, a margin of safety of −86.7%. That DCF projects free cash flow for 10 years, with growth starting at 8% and fading to 2.5%, discounted at 10%; it is one set of assumptions, not a forecast. Test your own in the Intrinsic Value Calculator.
How many of this site's 8 value filters does Veeva Systems pass?
VEEV passes 3 of 8. It passes Market Cap > $25B ($52.3B), Price/Book < 8 (7.03) and EPS Growth YoY > -5% (+38.7%). It misses Trailing P/E < 25 (51.49), PEG Ratio < 1.5 (2.09) and Price/Sales < 7 (15.11). vs 50-day MA (±12%) and vs 200-day MA (±12%) were not evaluated, because the moving-average checks only run on stocks that clear the fundamentals first. The 8-filter list shows every stock that passes all of them.
Are Veeva Systems's reported earnings reliable?
This site's earnings-quality check rates VEEV Mixed · 1 flag, 1 watch. Beneish M-score −2.62 · accruals −6.2% of assets · 159% of profit arrived as cash · stock comp 14.8% of revenue · share count +1.1% a year. From the latest 10-K (year to Jan 2026). Concerns: stock-based compensation (flagged) and share dilution (on watch). The five checks are the Beneish M-score (manipulation risk), accruals, cash conversion, stock-based compensation and share dilution; the Earnings Quality Screener shows how each is graded.
How fast has Veeva Systems grown its revenue and profit?
From fiscal 2017 to fiscal 2026, VEEV's revenue grew from $551 million to $3.2 billion, 21.6% a year. Net income went from $78.0 million to $909 million, and its net profit margin from 14.2% to 28.5%. Earnings per share went from $0.53 to $5.44 on today's share count, 29.5% a year. All figures are from VEEV's own 10-K filings (SEC EDGAR) and are shown year by year in the 10-Year Financials section of the card above.
Where is Veeva Systems trading compared with its 52-week range?
At $322.55, VEEV trades 113.3% above its 52-week low of $151.43 and 0.2% below its 52-week high of $323.08.
Where do these numbers come from?
- Financial statements: Veeva Systems's 10-K annual report for the year ended Jan 31, 2026, filed Mar 20, 2026 (filing index). Every earlier year in the 10-year financials comes from the company's older 10-K filings, all listed on SEC EDGAR.
- Prices and market data: quotes, P/E and analyst ratings from Finnhub; daily price history and the 52-week range from Twelve Data, both refreshed weekly. Short interest comes from FINRA, reported twice a month.
- How to check a figure: click any number in the card above to see its exact source, and read the Editorial Standards for every rule behind the checks.
About this Veeva Systems Inc analysis
This page shows every value-investing check the site runs on Veeva Systems Inc (VEEV) in one place: the 8 mechanical filters, the Buffett and Lynch checklists, a margin of safety from a disclosed DCF, earnings quality, shareholder yield and how it ranks against its sector peers. The numbers come from SEC filings and public market data, refreshed weekly, and the same rules apply to every stock on the stock list. See Editorial Standards for the sources and the rules, or run your own filters in the stock screener.